| Literature DB >> 32937903 |
Xiaoyi Gou1,2, Yun Li2, Chaonan Huang3, Xiuhua Zhu1,4, Jiping Chen2.
Abstract
Poly(2-(diethylamino)ethyl methacrylate-co-divinylbenzene) (poly(DEAEMA-co-DVB)) microspheres with mixed-mode weak anion-exchange (WAX) character were successfully fabricated for the first time via facile one-step Pickering emulsion polymerization. The obtained poly(DEAEMA-co-DVB) particles had good spherical geometry, uniform particle size in the range of 30-40 µm, a large specific surface area of 575 m2/g, and a pore size range of 5-30 nm, according to the SEM and nitrogen adsorption-desorption results. Using these mixed-mode WAX microspheres as packing material, a reliable and robust analytical method based on solid phase extraction and high performance liquid chromatography with ultraviolet detection (SPE-HPLC-UV) was developed for simultaneous determination of six strongly and weakly acidic nonsteroidal anti-inflammatory drugs (NSAIDs, niflumic acid, diflunisal, naproxen, ketoprofen, mefenamic acid, and diclofenac) in reservoir water. Under optimized conditions, it was applicable to preconcentrate up to 500 mL of reservoir water samples on the WAX cartridges with satisfying recoveries (88-96%) for all the NSAIDs tested. The limits of detection were in the range of 0.002-0.025 μg L-1, respectively. Our results showed that the developed mixed-mode WAX poly(DEAEMA-co-DVB) phase containing a tertiary amine with a pKa value of approximately 10.7 could be used for simultaneous clean-up and preconcentration of strongly and weakly acidic organic pollutants in real environmental water, which could not be achieved by single use of quaternary ammonium strong anion-exchange phase or weaker primary and secondary amine anion-exchange.Entities:
Keywords: Pickering emulsion polymerization; mixed-mode SPE; reservoir water; strongly and weakly acidic NSAIDs; weak anion-exchange
Year: 2020 PMID: 32937903 PMCID: PMC7570143 DOI: 10.3390/polym12092089
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic illustration for preparation of poly(DEAEMA-co-DVB) microspheres.
Figure 2SEM images of poly(DEAEMA-co-DVB) microspheres.
Figure 3(a) N2 adsorption–desorption isotherms; and (b) pore size distribution of poly(DEAEMA-co-DVB) microspheres.
Textural properties of the sorbent.
| SBET | Pore Volume | Pore Size | |
|---|---|---|---|
| Poly(DVB-co-DEAEMA) | 575 | 0.94 | 10–30 |
Figure 4FTIR spectra of poly(DEAEMA-co-DVB) microspheres.
The physical properties and structures of selected NSAIDs.
| Pharmaceutical | CAS Number | Structure | pKa | Log P | Water Solubility |
|---|---|---|---|---|---|
| niflumic acid | 4394-00-7 |
| 1.68 | 4.43 | 19 |
| naproxen | 22204-53-1 |
| 4.15 | 3.18 | 15.9 |
| diflunisal | 22494-42-4 |
| 3.3 | 4.44 | 14.5 |
| diclofenac | 15307-86-5 |
| 4.15 | 4.51 | 2.37 |
| ketoprofen | 22071-15-4 |
| 4.45 | 3.12 | 51 |
| mefenamic acid | 61-68-7 |
| 4.2 | 5.12 | 20 |
Figure 5Effects of sample pH on the recoveries (%) of selected pharmaceuticals, n = 3.
Figure 6Effects of elution volume on the recoveries (%) of selected pharmaceuticals, n = 3.
Figure 7Effects of sample volume on the recoveries (%) of selected pharmaceuticals, n = 3.
Liner regression, LODs, LOQs, and RSDs data for the poly(DEAEMA-co-DVB) based WAX SPE/HPLC-UV method.
| Analyte | Liner Range | Correlation of Determination (R2) | LOD a | LOQ a | Intra-Day RSD (%, n = 3) | Inter-Day RSD (%, n = 3) |
|---|---|---|---|---|---|---|
| naproxen | 0.01–10.0 | 0.995 | 0.011 | 0.032 | 0.3 | 3.3 |
| ketoprofen | 0.05–10.0 | 0.994 | 0.025 | 0.044 | 0.5 | 2.7 |
| diflunisal | 0.05–10.0 | 0.996 | 0.018 | 0.076 | 0.9 | 3.1 |
| mefenamic acid | 0.05–10.0 | 0.995 | 0.016 | 0.088 | 0.9 | 2.8 |
| diclofenac | 0.05–10.0 | 0.997 | 0.008 | 0.006 | 1.3 | 4.0 |
| niflumic acid | 0.05–10.0 | 0.997 | 0.002 | 0.003 | 2.1 | 3.3 |
a LODs and LOQs were estimated as the concentration where S/N = 3 and 10, respectively.
Recoveries (%) and RSDs after the WAX based SPE of 500 mL of reservoir water samples at two different spiked levels.
| Analyte | Spiked Levels a | |||
|---|---|---|---|---|
| (1) | (2) | |||
| Eluate b | RSD% | Eluate | RSD% | |
| naproxen | 101.3 | 2.7 | 92.0 | 3.6 |
| ketoprofen | 93.3 | 1.8 | 101.7 | 4.4 |
| diflunisal | 89.5 | 7.7 | 98.4 | 5.6 |
| mefenamic acid | 92.4 | 1.4 | 93.6 | 7.2 |
| diclofenac | 96.6 | 2.2 | 88.3 | 2.7 |
| niflumic acid | 90.6 | 4.6 | 90.1 | 3.5 |
a (1) Spiked at 0.05 μg/L of NAP and 0.5 μg/L of KEP, DIF, MEF, DIC, and NIF; and (2) Spiked at 0.5 μg/L of NAP and 5 μg/L of KEP, DIF, MEF, DIC, and NIF. b Eluate was obtained using 2 mL of 2% NH3·H2O/MeOH as eluent.
Comparison of recovery performance between poly(DEAEMA-co-DVB) with commercial SPE columns.
| Analyte | Poly(DEAEMA-co-DVB) a | Oasis MAX a | C18 a |
|---|---|---|---|
| naproxen | 90 | 93 | 70 |
| ketoprofen | 98 | 93 | 73 |
| diflunisal | 92 | 90 | 66 |
| mefenamic acid | 89 | 88 | 83 |
| diclofenac | 88 | 90 | 62 |
| niflumic acid | 93 | 7 | 69 |
a Spiked at 0.05 μg/L of NAP and 0.5 μg/L KEP, DIF, MEF, DIC, and NIF.